AMEENA ISA: Open Payments
NPI 1316139850 · PLANO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$199 in 10 payments from 7 companies in 2025. Trend: 2023 $516 · 2024 $262 · 2025 $199
Food & beverage: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 3 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $41 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $27 |
| Alkermes, Inc. | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: INVEGA SUSTENNA, COBENFY, CAPLYTA, VIVITROL, UZEDY, VRAYLAR, MOUNJARO.
Industry payments across TX — which companies pay providers there.
